Gene: CTNNBIP1
Official Full Name: catenin beta interacting protein 1provided by HGNC
Gene Summary: The protein encoded by this gene binds CTNNB1 and prevents interaction between CTNNB1 and TCF family members. The encoded protein is a negative regulator of the Wnt signaling pathway. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO06055 | CTNNBIP1 Knockout cell line (HeLa) | Human | CTNNBIP1 | 1:3~1:6 | Negative | Online Inquiry |
KO06056 | CTNNBIP1 Knockout cell line (HCT 116) | Human | CTNNBIP1 | 1:2~1:4 | Negative | Online Inquiry |
KO06057 | CTNNBIP1 Knockout cell line (HEK293) | Human | CTNNBIP1 | 1:3~1:6 | Negative | Online Inquiry |
KO06058 | CTNNBIP1 Knockout cell line (A549) | Human | CTNNBIP1 | 1:3~1:4 | Negative | Online Inquiry |
CTNNBIP1 Gene Knockout Cell Lines are specialized cellular models created through the targeted deletion of the CTNNBIP1 gene, also known as the Catenin Beta Interacting Protein 1 gene. This gene plays a pivotal role in the canonical Wnt signaling pathway, which is crucial for various cellular processes, including cell proliferation, differentiation, and apoptosis. By leveraging CRISPR/Cas9 technology, these knockout cell lines provide a precise and efficient means of studying the function of CTNNBIP1 in both physiological and pathological contexts.
The primary function of the CTNNBIP1 Gene Knockout Cell Lines is to facilitate the investigation of the gene’s role in cellular signaling and its implications in various diseases, including cancer. The absence of CTNNBIP1 alters the downstream Wnt signaling pathway, allowing researchers to explore how these changes affect cellular behavior. This mechanistic understanding is essential for driving innovation in therapeutic approaches, particularly in oncology where aberrations in Wnt signaling are frequently observed.
The scientific importance of these cell lines extends to their application in fundamental research and translational medicine. They serve as invaluable tools in drug discovery, allowing for the testing of compounds that can modulate Wnt pathway activity. Furthermore, they are instrumental in elucidating the mechanisms of disorders linked with dysfunctional Wnt signaling, paving the way for the development of novel therapeutic strategies.
One of the standout advantages of CTNNBIP1 Gene Knockout Cell Lines is their specificity and reproducibility, which surpasses alternatives such as RNA interference models that may not achieve complete gene suppression. Additionally, utilizing CRISPR/Cas9 ensures a genetic background that closely mimics in vivo conditions, providing more reliable data that can be extrapolated to human biology.
For researchers and clinicians focused on cancer biology, developmental studies, or therapeutic target identification, CTNNBIP1 Gene Knockout Cell Lines deliver unparalleled insights into cellular dynamics and disease mechanisms. Our company brings expertise in genetic engineering and cell line development, ensuring that each product is manufactured to the highest standards of quality and precision. By incorporating these knockout cell lines into your research, you equip yourself with powerful tools that can advance the field of biomedical research and contribute significantly to clinical outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.